ISSUES OF OPTIMIZATION OF METHOTREXATE THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS

ISSUES OF OPTIMIZATION OF METHOTREXATE THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS

Objective: to evaluate the safety and efficiency of monotherapy with methotrexate (MTX) solution for subcutaneous injection (SC MTX), by using the estimated dosing, in patients with rheumatoid arthritis (RA).Subjects and methods. A 12-month prospective controlled study enrolled 106 patients with ear...

Full description

Bibliographic Details
Main Authors:	G. I. Gridneva, Yu. V. Muravyev, E. L. Luchikhina, N. V. Demidova, D. E. Karateev
Format:	Article
Language:	Russian
Published:	IMA PRESS LLC 2017-03-01
Series:	Научно-практическая ревматология
Subjects:	methotrexate optimization rheumatoid arthritis body mass index remarca.
Online Access:	https://rsp.mediar-press.net/rsp/article/view/2337

Similar Items

USE OF SUBCUTANEOUS METHOTREXATE FOR THE TREATMENT OF PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS: THE REMARCA TRIAL
by: D. E. Karateev, et al.
Published: (2016-07-01)

The first Russian strategic study of pharmacotherapy for rheumatoid arthritis (REMARCA)
by: Dmitri Evgenyevich Karateev, et al.
Published: (2013-04-01)

IMPACT OF ANTIRHEUMATIC THERAPY ON THE LEVEL OF N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS
by: I. G. Kirillova, et al.
Published: (2018-07-01)

CARDIOVASCULAR RISK ASSESSMENT IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS WITHIN THE REMARCA STUDY: PRELIMINARY DATA
by: D. S. Novikova, et al.
Published: (2015-03-01)

TIME COURSE OF CHANGES IN BLOOD LIPID PARAMETERS IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS DURING TREAT-TO-TARGET ANTIRHEUMATIC THERAPY: ACCORDING TO 18-MONTH FOLLOW-UP FINDINGS
by: E. V. Udachkina, et al.
Published: (2016-07-01)

SAFETY OF USING METHOTREXATE SOLUTION FOR SUBCUTANEOUS INJECTIONS IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: Yu. V. Muravyev, et al.
Published: (2015-09-01)

NEW RECOMMENDATIONS FOR THE MANAGEMENT OF RHEUMATOID ARTHRITIS (EULAR, 2013): THE ROLE OF METHOTREXATE
by: Evgeniy L Nasonov, et al.
Published: (2014-03-01)

The relationship between the efficacy of methotrexate in rheumatoid arthritis and the achieved level of its polyglutamates in erythrocytes (pilot study)
by: G. I. Gridneva, et al.
Published: (2019-05-01)

Therapeutic drug monitoring of methotrexate and its metabolites in the red blood cells and mononuclear cells of patients with rheumatoid arthritis
by: G. I. Gridneva, et al.
Published: (2020-11-01)

The reaction of the skin and its appendages in rheumatoid arthritis patients using subcutaneous methotrexate: A description of three cases
by: Yu. V. Muravyev, et al.
Published: (2016-10-01)

COMPARATIVE EFFICIENCY AND TOLERABILITY OF CURRENT THERAPIES FOR EARLY RHEUMATOID ARTHRITIS
by: E. V. Fedorenko, et al.
Published: (2015-04-01)

Influence of therapy with methotrexate, sulfasalazine and glucocorticoids on disease activity and erosions progression in patients with early rheumatoid arthritis
by: G Togizbaev, et al.
Published: (2007-10-01)

Analysis of the relationship between the response to methotrexate therapy and its pharmacokinetic parameters in rheumatoid arthritis. Sovremennaya Revmatologiya
by: G. I. Gridneva, et al.
Published: (2022-08-01)

ANALYSIS OF GENE EXPRESSION IN BLOOD AS AN ADDITIONAL TOOL TO MONITOR METHOTREXATE THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: Elena Vasilyevna Chetina, et al.
Published: (2014-02-01)

NEW POSSIBILITIES FOR MONITORING METHOTREXATE EFFICACY IN RHEUMATOID ARTHRITIS
by: Yu. V. Muravyev
Published: (2015-09-01)

N-terminal pro-brain natriuretic peptide levels and diastolic dysfunction in patients with early rheumatoid arthritis before the administration of disease-modifying antirheumatic drugs
by: I G Kirillova, et al.
Published: (2016-05-01)

METHOTREXATE IN RHEUMATOID ARTHRITIS – 2015: NEW FACTS AND IDEAS
by: E. L. Nasonov
Published: (2016-12-01)

METHOTREXATE IN RHEUMATOID ARTHRITIS – 2015: NEW FACTS AND IDEAS
by: E. L. Nasonov
Published: (2015-09-01)

METHOTREXATE IN RHEUMATOID ARTHRITIS – 2015: NEW FACTS AND IDEAS
by: E. L. Nasonov
Published: (2015-10-01)

Patterns of Cytopenias Associated with Methotrexate Treated Rheumatoid Arthritis Patients
by: Mohsin Shakoor Malik, et al.
Published: (2023-04-01)

WHY ARE THE RECOMMENDED METHOTREXATE DOSES NOT USED FOR THE TREATMENT OF RHEUMATOID ARTHRITIS: WHO IS GUILTY AND WHAT TO DO?
by: Yu. V. Muravyev, et al.
Published: (2017-03-01)

CHANGES OF CYTOKINE LEVELS DURING THERAPY WITH METHOTREXATE AND ADALIMUMAB IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS (REMARCA STUDY)
by: A. S. Avdeeva, et al.
Published: (2014-06-01)

What do we know about the possibility of predicting the potential efficacy and safety of methotrexate, by measuring the concentration of its metabolites in rheumatoid arthritis?
by: G. I. Gridneva, et al.
Published: (2020-09-01)

METHOTREXATE — «GOLD STANDARD» OF JUVENILE RHEUMATOID ARTHRITIS TREATMENT
by: Ye. I. Alekseyeva, et al.
Published: (2011-01-01)

METHOTREXATE — «GOLD STANDARD» OF JUVENILE RHEUMATOID ARTHRITIS TREATMENT
by: Ye. I. Alekseyeva, et al.
Published: (2011-01-01)

Combined therapy with prospidin and methotrexate in rheumatoid arthritis (12 months controlled study)
by: B. F. Nemtsov, et al.
Published: (2003-06-01)

High frequency of methotrexate intolerance in longstanding rheumatoid arthritis: using the methotrexate intolerance severity score (MISS)
by: Jéssica Martins Amaral, et al.
Published: (2020-08-01)

Methotrexate Discontinuation and Dose Decreases After Therapy With Tocilizumab: Results From the Corrona Rheumatoid Arthritis Registry
by: Dimitrios A. Pappas, et al.
Published: (2020-03-01)

THE FIRST RUSSIAN STRATEGIC STUDY OF PHARMACOTHERAPY FOR RHEUMATOID ARTHRITIS (REMARCA TRIAL): RESULTS OF 12-MONTH TREATMENT IN 130 PATIENTS
by: D. E. Karateev, et al.
Published: (2015-10-01)

THE FIRST RUSSIAN STRATEGIC STUDY OF PHARMACOTHERAPY FOR RHEUMATOID ARTHRITIS (REMARCA TRIAL): RESULTS OF 12-MONTH TREATMENT IN 130 PATIENTS
by: D. E. Karateev, et al.
Published: (2014-12-01)

ASSOCIATION OF BLOOD GENE EXPRESSIONS IN RHEUMATOID ARTHRITIS PATIENTS WITH CLINICAL AND LABORATORY PARAMETERS BEFORE AND AFTER METHOTREXATE THERAPY
by: E. V. Chetina, et al.
Published: (2016-07-01)

Analysis of Disease Activity Metrics in a Methotrexate Withdrawal Study among Patients with Rheumatoid Arthritis Treated with Tofacitinib plus Methotrexate
by: Roy Fleischmann, et al.
Published: (2022-12-01)

The impact on disability of initial treatment with methotrexate in patients with rheumatoid arthritis: results from the MARI study
by: M. Manara, et al.
Published: (2016-12-01)

ROLE OF MATRIX METALLOPROTEINASE 3 IN PREDICTING THE EFFICIENCY OF THERAPY FOR EARLY RHEUMATOID ARTHRITIS: THE REMARCA TRIAL
by: A. S. Avdeeva, et al.
Published: (2016-03-01)

RETRACTED: Herpes Zoster in RA Patient treated with methotrexate
by: Yu. V. Muraviev, et al.
Published: (2022-06-01)

A 16-week multicenter observational study of the efficiency and safety of rheumatoid arthritis therapy with methotrexate
by: R. M. Balabanova
Published: (2018-12-01)

TWELVE-WEEK MULTICENTER OPEN-LABEL RANDOMIZED COMPARATIVE STUDY OF THE EFFICACY AND SAFETY OF METHOTREXATE AS A CONCENTRATED SOLUTION FOR SUBCUTANEOUS ADMINISTRATION AND AS 15-MG TABLETS PER WEEK FOR RHEUMATOID ARTHRITIS
by: Yu. V. Muravyev, et al.
Published: (2016-07-01)

Application of Microsponge Drug Platform to Enhance Methotrexate Administration in Rheumatoid Arthritis Therapy
by: Noemi Fiaschini, et al.
Published: (2024-12-01)

MTHFR and MTRR Genetic Polymorphism of Methotrexate Therapy Outcomes in Early Rheumatoid Arthritis
by: Zhang Q, et al.
Published: (2023-05-01)

EFFICIENCY OF TRIPLE (METHOTREXATE + SULFASALAZINE + HYDROXYCHLOROQUINE) COMBINATION DISEASE-MODIFYING THERAPY VERSUS METOTREXATE MONOTHERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: E E Gubar', et al.
Published: (2011-04-01)